|Mr. Michael E. Macaluso||Founder, Chairman & CEO||305k||N/A||1952|
|Mr. Thomas E. Chilcott III||CFO, Treasurer & Sec.||255k||N/A||1968|
|Ms. Holli Cherevka||Chief Operating Officer||205k||N/A||1983|
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. The company is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds. Its product pipeline includes Ampion, an intra-articular injection for the treatment of osteoarthritis of the knee. Ampio Pharmaceuticals, Inc. is headquartered in Englewood, Colorado.
Ampio Pharmaceuticals, Inc.’s ISS Governance QualityScore as of April 1, 2019 is 10. The pillar scores are Audit: 5; Board: 9; Shareholder Rights: 4; Compensation: 10.